Nab Technology: A Drug Delivery Platform Utilizing Endothelial gp60 Receptor-based Transport and' Tumor-derived SPARC for Targeting.

Printer-friendly versionPDF version
TitleNab Technology: A Drug Delivery Platform Utilizing Endothelial gp60 Receptor-based Transport and' Tumor-derived SPARC for Targeting.
Publication TypeWeb Article
Year of Publication2008
AuthorsDesai, N
PublisherFDA
URLhttp://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies/UCM289191.pdf
Citation Key267